Censa Pharmaceuticals
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
(Cancelled)
$65M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's bio-medical therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
+1 (781) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Censa Pharmaceuticals’s full profile, request a free trial.
Censa Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Jan-2018 | $65M | 0000 | Cancelled | Generating Revenue | |
| 2. Early Stage VC | 21-Nov-2017 | 00.00 | 00.000 | Completed | Startup | |
| 1. Angel (individual) | 19-Apr-2016 | $1.51M | $1.51M | 000.00 | Completed | Startup |
Censa Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
Censa Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Arkin Holdings | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| InClin | Other | Minority | 000 0000 | 000000 0 |
Censa Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Johnathan Reis MD | President, Chief Executive Officer & Board Member | ||
| Christopher Schelling | Founder and Board Member |
Censa Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christopher Schelling | Self | Founder and Board Member | 000 0000 | |
| Johnathan Reis MD | Censa Pharmaceuticals | President, Chief Executive Officer & Board Member | 000 0000 | |
| Joseph Baron | Censa Pharmaceuticals | Board Member | 000 0000 | |
| Pini Orbach Ph.D | Arkin Holdings | Board Member | 000 0000 |